Reuters logo
BRIEF-Baxter International says received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology
May 3, 2017 / 12:54 PM / 7 months ago

BRIEF-Baxter International says received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

May 3 (Reuters) - Baxter International Inc

* Baxter International Inc - received guidance from FDA clarifying regulatory pathway for new peritoneal dialysis technology

* Baxter International Inc - Baxter plans to have first patient on therapy with new system, as part of a clinical trial in 2018

* Baxter International Inc - regulatory submission is expected in 2019 for new peritoneal dialysis technology Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below